Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Anal and Colorectal Cancer Market Growth (Status and Outlook) 2022-2028

  • LP 4925405
  • 110 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Anal and Colorectal Cancer will have significant change from previous year. According to our (LP Information) latest study, the global Anal and Colorectal Cancer market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Anal and Colorectal Cancer market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Anal and Colorectal Cancer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anal and Colorectal Cancer market, reaching US$ million by the year 2028. As for the Europe Anal and Colorectal Cancer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Anal and Colorectal Cancer players cover Abbott Diagnostics, Advaxis, Abbott, and Amgen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Anal and Colorectal Cancer market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Surgery

Radiation therapy

Colorectal cancer chemotherapy

Targeted therapy

Immunotherapy

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Ambulatory surgery centers

Cancer research centers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Abbott Diagnostics

Advaxis

Abbott

Amgen

Atara Biotherapeutics

Bayer

Metabiomics

Beckman Coulter

BeiGene

Boehringer Ingelheim

Clinical Genomics

EDP Biotech

Eli Lilly

Epigenomics

Exact Sciences

Genomictree

Immunovaccine

ISA Pharmaceuticals

Merck

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anal and Colorectal Cancer Market Size 2017-2028

2.1.2 Anal and Colorectal Cancer Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Anal and Colorectal Cancer Segment by Type

2.2.1 Surgery

2.2.2 Radiation therapy

2.2.3 Colorectal cancer chemotherapy

2.2.4 Targeted therapy

2.2.5 Immunotherapy

2.3 Anal and Colorectal Cancer Market Size by Type

2.3.1 Anal and Colorectal Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

2.4 Anal and Colorectal Cancer Segment by Application

2.4.1 Hospitals

2.4.2 Ambulatory surgery centers

2.4.3 Cancer research centers

2.5 Anal and Colorectal Cancer Market Size by Application

2.5.1 Anal and Colorectal Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

3 Anal and Colorectal Cancer Market Size by Player

3.1 Anal and Colorectal Cancer Market Size Market Share by Players

3.1.1 Global Anal and Colorectal Cancer Revenue by Players (2020-2022)

3.1.2 Global Anal and Colorectal Cancer Revenue Market Share by Players (2020-2022)

3.2 Global Anal and Colorectal Cancer Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Anal and Colorectal Cancer by Regions

4.1 Anal and Colorectal Cancer Market Size by Regions (2017-2022)

4.2 Americas Anal and Colorectal Cancer Market Size Growth (2017-2022)

4.3 APAC Anal and Colorectal Cancer Market Size Growth (2017-2022)

4.4 Europe Anal and Colorectal Cancer Market Size Growth (2017-2022)

4.5 Middle East & Africa Anal and Colorectal Cancer Market Size Growth (2017-2022)

5 Americas

5.1 Americas Anal and Colorectal Cancer Market Size by Country (2017-2022)

5.2 Americas Anal and Colorectal Cancer Market Size by Type (2017-2022)

5.3 Americas Anal and Colorectal Cancer Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anal and Colorectal Cancer Market Size by Region (2017-2022)

6.2 APAC Anal and Colorectal Cancer Market Size by Type (2017-2022)

6.3 APAC Anal and Colorectal Cancer Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Anal and Colorectal Cancer by Country (2017-2022)

7.2 Europe Anal and Colorectal Cancer Market Size by Type (2017-2022)

7.3 Europe Anal and Colorectal Cancer Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anal and Colorectal Cancer by Region (2017-2022)

8.2 Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2017-2022)

8.3 Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Anal and Colorectal Cancer Market Forecast

10.1 Global Anal and Colorectal Cancer Forecast by Regions (2023-2028)

10.1.1 Global Anal and Colorectal Cancer Forecast by Regions (2023-2028)

10.1.2 Americas Anal and Colorectal Cancer Forecast

10.1.3 APAC Anal and Colorectal Cancer Forecast

10.1.4 Europe Anal and Colorectal Cancer Forecast

10.1.5 Middle East & Africa Anal and Colorectal Cancer Forecast

10.2 Americas Anal and Colorectal Cancer Forecast by Country (2023-2028)

10.2.1 United States Anal and Colorectal Cancer Market Forecast

10.2.2 Canada Anal and Colorectal Cancer Market Forecast

10.2.3 Mexico Anal and Colorectal Cancer Market Forecast

10.2.4 Brazil Anal and Colorectal Cancer Market Forecast

10.3 APAC Anal and Colorectal Cancer Forecast by Region (2023-2028)

10.3.1 China Anal and Colorectal Cancer Market Forecast

10.3.2 Japan Anal and Colorectal Cancer Market Forecast

10.3.3 Korea Anal and Colorectal Cancer Market Forecast

10.3.4 Southeast Asia Anal and Colorectal Cancer Market Forecast

10.3.5 India Anal and Colorectal Cancer Market Forecast

10.3.6 Australia Anal and Colorectal Cancer Market Forecast

10.4 Europe Anal and Colorectal Cancer Forecast by Country (2023-2028)

10.4.1 Germany Anal and Colorectal Cancer Market Forecast

10.4.2 France Anal and Colorectal Cancer Market Forecast

10.4.3 UK Anal and Colorectal Cancer Market Forecast

10.4.4 Italy Anal and Colorectal Cancer Market Forecast

10.4.5 Russia Anal and Colorectal Cancer Market Forecast

10.5 Middle East & Africa Anal and Colorectal Cancer Forecast by Region (2023-2028)

10.5.1 Egypt Anal and Colorectal Cancer Market Forecast

10.5.2 South Africa Anal and Colorectal Cancer Market Forecast

10.5.3 Israel Anal and Colorectal Cancer Market Forecast

10.5.4 Turkey Anal and Colorectal Cancer Market Forecast

10.5.5 GCC Countries Anal and Colorectal Cancer Market Forecast

10.6 Global Anal and Colorectal Cancer Forecast by Type (2023-2028)

10.7 Global Anal and Colorectal Cancer Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott Diagnostics

11.1.1 Abbott Diagnostics Company Information

11.1.2 Abbott Diagnostics Anal and Colorectal Cancer Product Offered

11.1.3 Abbott Diagnostics Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Diagnostics Main Business Overview

11.1.5 Abbott Diagnostics Latest Developments

11.2 Advaxis

11.2.1 Advaxis Company Information

11.2.2 Advaxis Anal and Colorectal Cancer Product Offered

11.2.3 Advaxis Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Advaxis Main Business Overview

11.2.5 Advaxis Latest Developments

11.3 Abbott

11.3.1 Abbott Company Information

11.3.2 Abbott Anal and Colorectal Cancer Product Offered

11.3.3 Abbott Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Abbott Main Business Overview

11.3.5 Abbott Latest Developments

11.4 Amgen

11.4.1 Amgen Company Information

11.4.2 Amgen Anal and Colorectal Cancer Product Offered

11.4.3 Amgen Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Amgen Main Business Overview

11.4.5 Amgen Latest Developments

11.5 Atara Biotherapeutics

11.5.1 Atara Biotherapeutics Company Information

11.5.2 Atara Biotherapeutics Anal and Colorectal Cancer Product Offered

11.5.3 Atara Biotherapeutics Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Atara Biotherapeutics Main Business Overview

11.5.5 Atara Biotherapeutics Latest Developments

11.6 Bayer

11.6.1 Bayer Company Information

11.6.2 Bayer Anal and Colorectal Cancer Product Offered

11.6.3 Bayer Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Bayer Main Business Overview

11.6.5 Bayer Latest Developments

11.7 Metabiomics

11.7.1 Metabiomics Company Information

11.7.2 Metabiomics Anal and Colorectal Cancer Product Offered

11.7.3 Metabiomics Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Metabiomics Main Business Overview

11.7.5 Metabiomics Latest Developments

11.8 Beckman Coulter

11.8.1 Beckman Coulter Company Information

11.8.2 Beckman Coulter Anal and Colorectal Cancer Product Offered

11.8.3 Beckman Coulter Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Beckman Coulter Main Business Overview

11.8.5 Beckman Coulter Latest Developments

11.9 BeiGene

11.9.1 BeiGene Company Information

11.9.2 BeiGene Anal and Colorectal Cancer Product Offered

11.9.3 BeiGene Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 BeiGene Main Business Overview

11.9.5 BeiGene Latest Developments

11.10 Boehringer Ingelheim

11.10.1 Boehringer Ingelheim Company Information

11.10.2 Boehringer Ingelheim Anal and Colorectal Cancer Product Offered

11.10.3 Boehringer Ingelheim Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Boehringer Ingelheim Main Business Overview

11.10.5 Boehringer Ingelheim Latest Developments

11.11 Clinical Genomics

11.11.1 Clinical Genomics Company Information

11.11.2 Clinical Genomics Anal and Colorectal Cancer Product Offered

11.11.3 Clinical Genomics Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Clinical Genomics Main Business Overview

11.11.5 Clinical Genomics Latest Developments

11.12 EDP Biotech

11.12.1 EDP Biotech Company Information

11.12.2 EDP Biotech Anal and Colorectal Cancer Product Offered

11.12.3 EDP Biotech Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 EDP Biotech Main Business Overview

11.12.5 EDP Biotech Latest Developments

11.13 Eli Lilly

11.13.1 Eli Lilly Company Information

11.13.2 Eli Lilly Anal and Colorectal Cancer Product Offered

11.13.3 Eli Lilly Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Eli Lilly Main Business Overview

11.13.5 Eli Lilly Latest Developments

11.14 Epigenomics

11.14.1 Epigenomics Company Information

11.14.2 Epigenomics Anal and Colorectal Cancer Product Offered

11.14.3 Epigenomics Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Epigenomics Main Business Overview

11.14.5 Epigenomics Latest Developments

11.15 Exact Sciences

11.15.1 Exact Sciences Company Information

11.15.2 Exact Sciences Anal and Colorectal Cancer Product Offered

11.15.3 Exact Sciences Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Exact Sciences Main Business Overview

11.15.5 Exact Sciences Latest Developments

11.16 Genomictree

11.16.1 Genomictree Company Information

11.16.2 Genomictree Anal and Colorectal Cancer Product Offered

11.16.3 Genomictree Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Genomictree Main Business Overview

11.16.5 Genomictree Latest Developments

11.17 Immunovaccine

11.17.1 Immunovaccine Company Information

11.17.2 Immunovaccine Anal and Colorectal Cancer Product Offered

11.17.3 Immunovaccine Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Immunovaccine Main Business Overview

11.17.5 Immunovaccine Latest Developments

11.18 ISA Pharmaceuticals

11.18.1 ISA Pharmaceuticals Company Information

11.18.2 ISA Pharmaceuticals Anal and Colorectal Cancer Product Offered

11.18.3 ISA Pharmaceuticals Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 ISA Pharmaceuticals Main Business Overview

11.18.5 ISA Pharmaceuticals Latest Developments

11.19 Merck

11.19.1 Merck Company Information

11.19.2 Merck Anal and Colorectal Cancer Product Offered

11.19.3 Merck Anal and Colorectal Cancer Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Merck Main Business Overview

11.19.5 Merck Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Anal and Colorectal Cancer Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Surgery

Table 3. Major Players of Radiation therapy

Table 4. Major Players of Colorectal cancer chemotherapy

Table 5. Major Players of Targeted therapy

Table 6. Major Players of Immunotherapy

Table 7. Anal and Colorectal Cancer Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Anal and Colorectal Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

Table 10. Anal and Colorectal Cancer Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Anal and Colorectal Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

Table 13. Global Anal and Colorectal Cancer Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Anal and Colorectal Cancer Revenue Market Share by Player (2020-2022)

Table 15. Anal and Colorectal Cancer Key Players Head office and Products Offered

Table 16. Anal and Colorectal Cancer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Anal and Colorectal Cancer Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Anal and Colorectal Cancer Market Size Market Share by Regions (2017-2022)

Table 21. Americas Anal and Colorectal Cancer Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Anal and Colorectal Cancer Market Size Market Share by Country (2017-2022)

Table 23. Americas Anal and Colorectal Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

Table 25. Americas Anal and Colorectal Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

Table 27. APAC Anal and Colorectal Cancer Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Anal and Colorectal Cancer Market Size Market Share by Region (2017-2022)

Table 29. APAC Anal and Colorectal Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

Table 31. APAC Anal and Colorectal Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

Table 33. Europe Anal and Colorectal Cancer Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Anal and Colorectal Cancer Market Size Market Share by Country (2017-2022)

Table 35. Europe Anal and Colorectal Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

Table 37. Europe Anal and Colorectal Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Anal and Colorectal Cancer Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Anal and Colorectal Cancer Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Anal and Colorectal Cancer Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Anal and Colorectal Cancer

Table 46. Key Market Challenges & Risks of Anal and Colorectal Cancer

Table 47. Key Industry Trends of Anal and Colorectal Cancer

Table 48. Global Anal and Colorectal Cancer Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Anal and Colorectal Cancer Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Anal and Colorectal Cancer Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Anal and Colorectal Cancer Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Anal and Colorectal Cancer Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Anal and Colorectal Cancer Market Size Market Share Forecast by Application (2023-2028)

Table 54. Abbott Diagnostics Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 55. Abbott Diagnostics Anal and Colorectal Cancer Product Offered

Table 56. Abbott Diagnostics Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Abbott Diagnostics Main Business

Table 58. Abbott Diagnostics Latest Developments

Table 59. Advaxis Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 60. Advaxis Anal and Colorectal Cancer Product Offered

Table 61. Advaxis Main Business

Table 62. Advaxis Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Advaxis Latest Developments

Table 64. Abbott Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 65. Abbott Anal and Colorectal Cancer Product Offered

Table 66. Abbott Main Business

Table 67. Abbott Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Abbott Latest Developments

Table 69. Amgen Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 70. Amgen Anal and Colorectal Cancer Product Offered

Table 71. Amgen Main Business

Table 72. Amgen Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Amgen Latest Developments

Table 74. Atara Biotherapeutics Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 75. Atara Biotherapeutics Anal and Colorectal Cancer Product Offered

Table 76. Atara Biotherapeutics Main Business

Table 77. Atara Biotherapeutics Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Atara Biotherapeutics Latest Developments

Table 79. Bayer Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 80. Bayer Anal and Colorectal Cancer Product Offered

Table 81. Bayer Main Business

Table 82. Bayer Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Bayer Latest Developments

Table 84. Metabiomics Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 85. Metabiomics Anal and Colorectal Cancer Product Offered

Table 86. Metabiomics Main Business

Table 87. Metabiomics Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Metabiomics Latest Developments

Table 89. Beckman Coulter Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 90. Beckman Coulter Anal and Colorectal Cancer Product Offered

Table 91. Beckman Coulter Main Business

Table 92. Beckman Coulter Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Beckman Coulter Latest Developments

Table 94. BeiGene Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 95. BeiGene Anal and Colorectal Cancer Product Offered

Table 96. BeiGene Main Business

Table 97. BeiGene Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. BeiGene Latest Developments

Table 99. Boehringer Ingelheim Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 100. Boehringer Ingelheim Anal and Colorectal Cancer Product Offered

Table 101. Boehringer Ingelheim Main Business

Table 102. Boehringer Ingelheim Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Boehringer Ingelheim Latest Developments

Table 104. Clinical Genomics Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 105. Clinical Genomics Anal and Colorectal Cancer Product Offered

Table 106. Clinical Genomics Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Clinical Genomics Main Business

Table 108. Clinical Genomics Latest Developments

Table 109. EDP Biotech Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 110. EDP Biotech Anal and Colorectal Cancer Product Offered

Table 111. EDP Biotech Main Business

Table 112. EDP Biotech Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. EDP Biotech Latest Developments

Table 114. Eli Lilly Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 115. Eli Lilly Anal and Colorectal Cancer Product Offered

Table 116. Eli Lilly Main Business

Table 117. Eli Lilly Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Eli Lilly Latest Developments

Table 119. Epigenomics Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 120. Epigenomics Anal and Colorectal Cancer Product Offered

Table 121. Epigenomics Main Business

Table 122. Epigenomics Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Epigenomics Latest Developments

Table 124. Exact Sciences Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 125. Exact Sciences Anal and Colorectal Cancer Product Offered

Table 126. Exact Sciences Main Business

Table 127. Exact Sciences Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Exact Sciences Latest Developments

Table 129. Genomictree Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 130. Genomictree Anal and Colorectal Cancer Product Offered

Table 131. Genomictree Main Business

Table 132. Genomictree Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Genomictree Latest Developments

Table 134. Immunovaccine Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 135. Immunovaccine Anal and Colorectal Cancer Product Offered

Table 136. Immunovaccine Main Business

Table 137. Immunovaccine Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Immunovaccine Latest Developments

Table 139. ISA Pharmaceuticals Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 140. ISA Pharmaceuticals Anal and Colorectal Cancer Product Offered

Table 141. ISA Pharmaceuticals Main Business

Table 142. ISA Pharmaceuticals Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. ISA Pharmaceuticals Latest Developments

Table 144. Merck Details, Company Type, Anal and Colorectal Cancer Area Served and Its Competitors

Table 145. Merck Anal and Colorectal Cancer Product Offered

Table 146. Merck Main Business

Table 147. Merck Anal and Colorectal Cancer Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Merck Latest Developments

List of Figures

Figure 1. Anal and Colorectal Cancer Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Anal and Colorectal Cancer Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Anal and Colorectal Cancer Market Size Market Share by Type in 2021

Figure 7. Anal and Colorectal Cancer in Hospitals

Figure 8. Global Anal and Colorectal Cancer Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Anal and Colorectal Cancer in Ambulatory surgery centers

Figure 10. Global Anal and Colorectal Cancer Market: Ambulatory surgery centers (2017-2022) & ($ Millions)

Figure 11. Anal and Colorectal Cancer in Cancer research centers

Figure 12. Global Anal and Colorectal Cancer Market: Cancer research centers (2017-2022) & ($ Millions)

Figure 13. Global Anal and Colorectal Cancer Market Size Market Share by Application in 2021

Figure 14. Global Anal and Colorectal Cancer Revenue Market Share by Player in 2021

Figure 15. Global Anal and Colorectal Cancer Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Anal and Colorectal Cancer Market Size 2017-2022 ($ Millions)

Figure 17. APAC Anal and Colorectal Cancer Market Size 2017-2022 ($ Millions)

Figure 18. Europe Anal and Colorectal Cancer Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Anal and Colorectal Cancer Market Size 2017-2022 ($ Millions)

Figure 20. Americas Anal and Colorectal Cancer Value Market Share by Country in 2021

Figure 21. Americas Anal and Colorectal Cancer Consumption Market Share by Type in 2021

Figure 22. Americas Anal and Colorectal Cancer Market Size Market Share by Application in 2021

Figure 23. United States Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Anal and Colorectal Cancer Market Size Market Share by Region in 2021

Figure 28. APAC Anal and Colorectal Cancer Market Size Market Share by Application in 2021

Figure 29. China Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Anal and Colorectal Cancer Market Size Market Share by Country in 2021

Figure 36. Europe Anal and Colorectal Cancer Market Size Market Share by Type in 2021

Figure 37. Europe Anal and Colorectal Cancer Market Size Market Share by Application in 2021

Figure 38. Germany Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Anal and Colorectal Cancer Market Size Market Share by Application in 2021

Figure 46. Egypt Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Anal and Colorectal Cancer Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 52. APAC Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 53. Europe Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 55. United States Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 56. Canada Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 59. China Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 60. Japan Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 61. Korea Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 63. India Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 64. Australia Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 65. Germany Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 66. France Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 67. UK Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 68. Italy Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 69. Russia Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 70. Spain Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 73. Israel Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Anal and Colorectal Cancer Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450